Schramm R Dee, Paprocki Ann Marie, VandeVoort Catherine A
Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53715, USA.
Hum Reprod. 2003 Apr;18(4):826-33. doi: 10.1093/humrep/deg144.
Understanding the causes of developmental failure of in-vitro matured primate oocytes may lead to viable strategies for improving their developmental competence. The aims of this study were to determine whether the timely onset of embryonic genome activation among individual blastomeres of preimplantation macaque embryos is impaired by in-vitro maturation (IVM) of oocytes and whether these impairments are associated with developmental failure during the embryonically controlled period of preimplantation development.
Genome activation among individual blastomeres was assessed using expression of fibrillarin as a marker of nucleolar transcription. Immature oocytes were obtained from rhesus monkeys following treatment with recombinant human FSH and matured in-vitro in one of two IVM media (CMRLa or CMRLb). In-vivo matured oocytes were obtained from FSH treated monkeys following administration of hCG. Oocytes were fertilized in vitro and either cultured for developmental studies or processed at the 8-12-cell stage for expression of fibrillarin.
Developmental competence of embryos derived from in-vitro matured CMRLa oocytes was markedly (P < 0.05) impaired compared with those derived from in-vivo matured or in-vitro matured CMRLb oocytes. Developmental profiles were similar among the groups prior to the 8-cell stage. However, in embryos derived from in-vitro matured CMRLa oocytes, developmental failure increased significantly (P < 0.05) after the time of genome activation compared with those derived from in-vivo matured or in-vitro matured CMRLb oocytes. The mean percentages of non-activated blastomeres per embryo, as well as the proportions of embryos with at least one non-activated blastomere, or with no activated blastomeres, were all significantly (P < 0.05) greater in embryos derived from in-vitro matured CMRLa oocytes than in those derived from in-vivo matured or CMRLb oocytes.
The relatively poor developmental competence of in-vitro matured primate oocytes is likely caused in part by failure in the timely onset of embryonic genome activation resulting from incomplete cytoplasmic maturation.
了解体外成熟的灵长类卵母细胞发育失败的原因可能会带来提高其发育能力的可行策略。本研究的目的是确定卵母细胞体外成熟(IVM)是否会损害植入前猕猴胚胎单个卵裂球中胚胎基因组激活的及时启动,以及这些损害是否与植入前发育的胚胎控制期内的发育失败有关。
使用纤维蛋白原的表达作为核仁转录的标志物来评估单个卵裂球中的基因组激活。用重组人促卵泡激素处理恒河猴后获得未成熟卵母细胞,并在两种IVM培养基(CMRLa或CMRLb)之一中进行体外成熟。体内成熟的卵母细胞是在给恒河猴注射人绒毛膜促性腺激素后从接受促卵泡激素治疗的猴子中获得的。卵母细胞在体外受精,要么培养用于发育研究,要么在8-12细胞阶段进行处理以检测纤维蛋白原的表达。
与体内成熟或体外成熟的CMRLb卵母细胞来源的胚胎相比,体外成熟的CMRLa卵母细胞来源的胚胎发育能力明显受损(P < 0.05)。在8细胞阶段之前,各组的发育情况相似。然而,与体内成熟或体外成熟的CMRLb卵母细胞来源的胚胎相比,体外成熟的CMRLa卵母细胞来源的胚胎在基因组激活后发育失败显著增加(P < 0.05)。体外成熟的CMRLa卵母细胞来源的胚胎中,每个胚胎未激活的卵裂球的平均百分比,以及至少有一个未激活卵裂球或没有激活卵裂球的胚胎比例,均显著高于体内成熟或CMRLb卵母细胞来源的胚胎(P < 0.05)。
体外成熟的灵长类卵母细胞发育能力相对较差,可能部分是由于细胞质成熟不完全导致胚胎基因组激活未能及时启动所致。